Lv1
30 积分 2025-03-20 加入
Discrepant Outcomes of Direct Oral Anticoagulant Trials in Device-Detected Atrial Fibrillation after Stroke:Insights from NOAH-AFNET 6 and ARTESIA
1个月前
已完结
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc-Biomarkers model
2个月前
已关闭
Prediction of ischemic stroke by the CHA2DS2-VA score in an Asian population: A report from the prospective nationwide COOL-AF registry
2个月前
已完结
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
2个月前
已完结
Stroke risks in women vs men in Asian patients with atrial fibrillation: A temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores
2个月前
已关闭
Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors
2个月前
已完结
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores
2个月前
已关闭
From Bench to Bedside: The Clinical Relevance of Atrial Electrical Remodeling in Atrial Fibrillation Therapy
2个月前
已完结
Apixaban vs Aspirin According to CHA 2 DS 2 -VASc Score in Subclinical Atrial Fibrillation
5个月前
已完结
皖公网安备34019202002308
